News & Perspective

Jun 25, 2019

Jun 25, 2019

Stewardship / Resistance Scan for Jun 25, 2019

Highly resistant gonorrhea in Taiwan
New pneumonia antibiotic
UK AMR funding

Feb 08, 2019

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding

Oct 19, 2018

Oct 19, 2018

News Scan for Oct 19, 2018

More Ebola in Beni
New polio cases
NYC measles clusters
Dengvaxia approved in Europe
BSE on Scottish farm
Avian flu outbreaks in Vietnam and Bulgaria

Sep 14, 2018

Sep 14, 2018

ASP Scan (Weekly) for Sep 14, 2018

UK-India diagnostics effort
Probiotics and antibiotic use in kids
Candida auris in New York
Resistance and rising temps
European One Health AMR plan
India bans combo drugs
MDR bacteria in farmed salmon
Resistant E coli in dogs
Essential-antibiotic price hike
Antibiotics and cough
Piperacillin-tazobactam trial results
Double antibiotic for pneumonia
C diff in food animals
Accessible antimicrobial resistance data

Sep 18, 2017

Sep 18, 2017

Stewardship / Resistance Scan for Sep 18, 2017

Resistant E coli clone in kids
New pneumonia antibiotic
UK strep guidelines

Mar 17, 2017

Mar 17, 2017

ASP Scan (Weekly) for Mar 17, 2017

Animal antibiotic use
Antibiotic-resistant eye infections
Antibiotic misconceptions
Sexual spread of resistant bacteria
New gram-negative antibiotic
MDRO screening, isolation

Mar 09, 2010

Mar 09, 2010

ECDC sees another pandemic wave as unlikely

(CIDRAP News) – European countries won't likely experience another wave of pandemic H1N1 influenza cases this spring and summer, though the virus will probably continue to circulate and be the region's dominant strain for the next flu season, the European Centre for Disease Prevention and Control (ECDC) said today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»